Linked Data API

Show Search Form

Search Results

1697900
registered interest false remove filter
date less than 2024-03-21more like thismore than 2024-03-21
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Ovarian Cancer: Diagnosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether her Department plans to shorten the diagnostic pathway for ovarian cancer by allowing the CA125 blood test and ultrasound to be undertaken at the same time. more like this
tabling member constituency Slough more like this
tabling member printed
Mr Tanmanjeet Singh Dhesi remove filter
uin 19930 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-02more like thismore than 2024-04-02
answer text <p>The Department is supporting NHS England in developing Best Practice Timed pathways, to support the ongoing improvement effort to shorten diagnosis pathways, reduce variation, improve patient experience of care, and meet the Faster Diagnosis Standard. This standard ensures patients are told they have cancer, or that cancer is ruled out, within 28 days of urgent cancer referral from general practice or screening service.</p><p>In March 2023, NHS England published guidance for local health and care systems to implement a timed gynaecological cancer diagnostic pathway, including for ovarian cancer. The gynaecological pathway ensures that at day zero, when presenting with symptoms, an ultrasound and a minimum data set is obtained, which includes a full blood count. For patients with suspected ovarian cancer, the minimum dataset should also include tumour marker CA125, with confirmation of suspicious features of ovarian cancer on ultrasound.</p><p>The guidance further ensures that patients with persistent abdominal symptoms, raised CA125, and a normal pelvic scan should be referred through the non-specific symptoms rapid diagnostic centre pathway. Women over 50 years old with elevated CA125 and palpable mass or ascites, or both, or with a previous ultrasound with risk of malignancy, should be referred straight to a computed tomography scan.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
question first answered
remove maximum value filtermore like thismore than 2024-04-02T15:37:44.03Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4638
label Biography information for Mr Tanmanjeet Singh Dhesi more like this
1697901
registered interest false remove filter
date less than 2024-03-21more like thismore than 2024-03-21
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Ovarian Cancer: Diagnosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps she is taking to reduce regional variations in early diagnosis of ovarian cancer. more like this
tabling member constituency Slough more like this
tabling member printed
Mr Tanmanjeet Singh Dhesi remove filter
uin 19931 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-28more like thismore than 2024-03-28
answer text <p>Reducing inequalities and variation in cancer treatment is a priority for the Government, as is increasing early cancer diagnosis, as both are key contributors to reducing cancer health inequalities. The National Health Service is improving cancer pathways to get people diagnosed faster once referred, and is looking into alternative routes into the system, including non-specific symptom (NSS) pathways for patients who do not fit clearly into a single urgent cancer referral pathway, but who are at risk of being diagnosed with cancer. This will help support faster ovarian cancer diagnosis. 113 NSS pathways are currently operational, with more in development.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
question first answered
less than 2024-03-28T11:38:14.567Zmore like thismore than 2024-03-28T11:38:14.567Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4638
label Biography information for Mr Tanmanjeet Singh Dhesi more like this
1696676
registered interest false remove filter
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Medical Equipment more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if she will make an assessment of the adequacy of (a) funding and (b) support available for research into non-invasive cancer monitoring technologies. more like this
tabling member constituency Slough more like this
tabling member printed
Mr Tanmanjeet Singh Dhesi remove filter
uin 19142 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-26more like thismore than 2024-03-26
answer text <p>Research is crucial in tackling cancer, which is why the Department invests over £1 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23 and the NIHR spends more on cancer than any other disease group.</p><p>In terms of adequacy of funding, the NIHR funds research in response to proposals received from scientists, rather than allocating funding to specific disease areas. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.</p><p> </p><p>Regarding technologies, the NIHR’s Invention for Innovation (i4i) Programme is a translational research funding scheme aimed at supporting medical devices, such as non-invasive cancer monitoring technologies, and includes in vitro diagnostic devices and digital health technologies addressing an existing or emerging health or social care need. Further information is available at the following link:</p><p><a href="https://www.nihr.ac.uk/explore-nihr/funding-programmes/invention-for-innovation.htm" target="_blank">https://www.nihr.ac.uk/explore-nihr/funding-programmes/invention-for-innovation.htm</a></p><p>Additionally, in September 2023, the Office for Life Sciences Cancer Mission launched the £12 million NIHR i4i Cancer Mission: Early Cancer Diagnosis Clinical Validation and Evaluation Call, aiming to support the clinical validation and evaluation of breakthrough technologies that can increase the proportion of cancers that are detected earlier in the disease course and target health inequalities in cancer diagnosis.</p><p>The NIHR continues to welcome and encourage funding applications for research into any aspect of human health, including cancer monitoring technologies, and it is worth noting that all applications that were fundable in open competition, have been funded.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
question first answered
less than 2024-03-26T12:01:10.347Zmore like thismore than 2024-03-26T12:01:10.347Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4638
label Biography information for Mr Tanmanjeet Singh Dhesi more like this
1696677
registered interest false remove filter
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Health: Technology more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help encourage innovation in the development of healthcare technology for at home use. more like this
tabling member constituency Slough more like this
tabling member printed
Mr Tanmanjeet Singh Dhesi remove filter
uin 19143 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-26more like thismore than 2024-03-26
answer text <p>In February 2023, the Department published the MedTech strategy which outlined how we will work with key stakeholders, including technology developers and academia, to ensure the health and social care system can reliably access safe, effective, and innovative medical technologies. To accelerate the introduction of innovative medical solutions, we are working with stakeholders at pace to implement solutions to streamline and join-up the innovation adoption pathway, from providing clear signals to industry on the innovation we need, to reforming regulation, comparative assessment, and with clearer procurement pathways.</p><p> </p><p>In October 2023, the Government announced £30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund is supporting integrated care systems to invest in the latest technology to help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients. Thanks to this fund, tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes. In February 2024, the Government announced eight innovative tech companies who will be supported to bring their devices to market through the Innovative Devices Access Pathway (IDAP). One of the technologies allows chemotherapy patients to self-test at home, using a finger-prick blood test, for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive behaviour therapy, and targeted physical activity in a personally customisable format to help patients manage multiple sclerosis.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
grouped question UIN 19144 more like this
question first answered
less than 2024-03-26T11:31:48.523Zmore like thismore than 2024-03-26T11:31:48.523Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4638
label Biography information for Mr Tanmanjeet Singh Dhesi more like this
1696679
registered interest false remove filter
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Health: Technology more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether the NHS is taking steps with (a) technology developers and (b) academia to help accelerate the introduction of innovative medical solutions. more like this
tabling member constituency Slough more like this
tabling member printed
Mr Tanmanjeet Singh Dhesi remove filter
uin 19144 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-26more like thismore than 2024-03-26
answer text <p>In February 2023, the Department published the MedTech strategy which outlined how we will work with key stakeholders, including technology developers and academia, to ensure the health and social care system can reliably access safe, effective, and innovative medical technologies. To accelerate the introduction of innovative medical solutions, we are working with stakeholders at pace to implement solutions to streamline and join-up the innovation adoption pathway, from providing clear signals to industry on the innovation we need, to reforming regulation, comparative assessment, and with clearer procurement pathways.</p><p> </p><p>In October 2023, the Government announced £30 million of investment in the Health Tech Adoption and Acceleration Fund. The fund is supporting integrated care systems to invest in the latest technology to help cut waiting lists, speed up diagnosis, and deliver new and improved ways to treat patients. Thanks to this fund, tens of thousands of patients at risk of kidney disease will be able to get tested from the comfort of their own homes. In February 2024, the Government announced eight innovative tech companies who will be supported to bring their devices to market through the Innovative Devices Access Pathway (IDAP). One of the technologies allows chemotherapy patients to self-test at home, using a finger-prick blood test, for neutropenic sepsis. Another is a smartphone app that delivers exercises, cognitive behaviour therapy, and targeted physical activity in a personally customisable format to help patients manage multiple sclerosis.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
grouped question UIN 19143 more like this
question first answered
less than 2024-03-26T11:31:48.57Zmore like thismore than 2024-03-26T11:31:48.57Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4638
label Biography information for Mr Tanmanjeet Singh Dhesi more like this
1696681
registered interest false remove filter
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cancer: Medical Equipment more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of (a) the breast cancer monitoring device and (b) other innovative medical devices on (i) early cancer detection rates and (ii) patient outcomes. more like this
tabling member constituency Slough more like this
tabling member printed
Mr Tanmanjeet Singh Dhesi remove filter
uin 19145 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-26more like thismore than 2024-03-26
answer text <p>The Department has not yet assessed the potential impact of breast cancer monitoring devices. This technology is at an early stage and further evidence is needed before we can assess whether it could be trialled in medical settings.</p><p>Improving the early diagnosis of cancer, including breast cancers, is a priority for the National Health Service. NHS England has an ambition to diagnose 75% of cancers at stage one or two by 2028, which will help tens of thousands of people live for longer. NHS England is working to meet the Faster Diagnosis Standard (FDS) which sets a target of 28 days from urgent referral by a general practitioner or screening programme, to patients being told that they have cancer, or that cancer is ruled out.</p><p>In January 2022 the Department provided £10 million of funding for 28 new breast screening units and nearly 60 life-saving upgrades to services in the areas where they are most needed, so more women can be checked for signs of cancer, speeding up diagnosis and treatment.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
grouped question UIN 19146 more like this
question first answered
less than 2024-03-26T11:35:55.403Zmore like thismore than 2024-03-26T11:35:55.403Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4638
label Biography information for Mr Tanmanjeet Singh Dhesi more like this
1696682
registered interest false remove filter
date less than 2024-03-18more like thismore than 2024-03-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Breast Cancer more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of breast cancer monitoring devices on global health outcomes. more like this
tabling member constituency Slough more like this
tabling member printed
Mr Tanmanjeet Singh Dhesi remove filter
uin 19146 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-26more like thismore than 2024-03-26
answer text <p>The Department has not yet assessed the potential impact of breast cancer monitoring devices. This technology is at an early stage and further evidence is needed before we can assess whether it could be trialled in medical settings.</p><p>Improving the early diagnosis of cancer, including breast cancers, is a priority for the National Health Service. NHS England has an ambition to diagnose 75% of cancers at stage one or two by 2028, which will help tens of thousands of people live for longer. NHS England is working to meet the Faster Diagnosis Standard (FDS) which sets a target of 28 days from urgent referral by a general practitioner or screening programme, to patients being told that they have cancer, or that cancer is ruled out.</p><p>In January 2022 the Department provided £10 million of funding for 28 new breast screening units and nearly 60 life-saving upgrades to services in the areas where they are most needed, so more women can be checked for signs of cancer, speeding up diagnosis and treatment.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
grouped question UIN 19145 more like this
question first answered
less than 2024-03-26T11:35:55.447Zmore like thismore than 2024-03-26T11:35:55.447Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4638
label Biography information for Mr Tanmanjeet Singh Dhesi more like this
1696280
registered interest false remove filter
date less than 2024-03-14more like thismore than 2024-03-14
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Hospitals: Waiting Lists more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps her Department is taking to support hospital trusts with significant waiting lists to (a) share and (b) implement best practices in (i) England and (ii) Slough constituency. more like this
tabling member constituency Slough more like this
tabling member printed
Mr Tanmanjeet Singh Dhesi remove filter
uin 18767 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-20more like thismore than 2024-03-20
answer text <p>The National Health Service and the Department are aiming to transform elective care across England. This includes providing additional regional or national support and intervention to the most challenged trusts. We are driving activity by using wider system capacity, through use of the independent sector, mutual aid, offering patients a choice at the point of referral, and expanding and protecting elective planned diagnostic services through community diagnostic centres (CDC). In January 2024, a new CDC opened in Slough delivering additional checks, tests, and scans as mobile activity. To help manage the demand, the NHS is providing ongoing rigorous delivery monitoring, sharing best practice approaches between trusts, providing specialised advice in primary care, and driving productivity through pilot schemes and a new network of surgical hubs.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
question first answered
less than 2024-03-20T15:30:36.277Zmore like thismore than 2024-03-20T15:30:36.277Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4638
label Biography information for Mr Tanmanjeet Singh Dhesi more like this
1694538
registered interest false remove filter
date less than 2024-03-07more like thismore than 2024-03-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Health Services: Waiting Lists more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of NHS funding to tackle the backlog of (a) elective surgeries and (b) other non-emergency procedures. more like this
tabling member constituency Slough more like this
tabling member printed
Mr Tanmanjeet Singh Dhesi remove filter
uin 17645 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-14more like thismore than 2024-03-14
answer text <p>The Government is committed to making the best possible progress against the ambitions set out in the Elective Recovery Plan (ERP), despite a range of constraints that have impacted on delivery. These constraints have included, but were not limited to, higher than expected COVID-19 and non-COVID-19 related bed occupancy, and periods of disruptive industrial action.</p><p>The Government regularly reviews progress against the ambitions in the ERP, including affordability, and the impact of the constraints listed above. The Government is planning to spend more than £8 billion from 2022/23 to 2024/25, to help drive up and protect elective activity.</p><p>This is supported by NHS England’s planning guidance, which in 2023/24 set an initial elective recovery target of 107%, delivered through a payment-by-result mechanism. To reflect the impact of industrial action, the Government and NHS England agreed to revise the elective activity target to 103% for the remainder of 2023/24, and in November 2023 provided an additional £800 million of funding from a combination of reprioritised and new funding, to mitigate the costs of industrial action. Planning guidance for 2024/25 will set out the ambitions for 2024/25, and will be published shortly.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
question first answered
less than 2024-03-14T14:08:13.363Zmore like thismore than 2024-03-14T14:08:13.363Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4638
label Biography information for Mr Tanmanjeet Singh Dhesi more like this
1694539
registered interest false remove filter
date less than 2024-03-07more like thismore than 2024-03-07
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading NHS: Standards more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to the Comment entitled Health spending planned to fall in England and Scotland in 2024–25, suggesting a top-up likely, published by the Institute for Fiscal Studies on 4 March 2024, what steps he is taking to help ensure the NHS maintains (a) quality of care and (b) patient outcomes in the 2024/25 financial year. more like this
tabling member constituency Slough more like this
tabling member printed
Mr Tanmanjeet Singh Dhesi remove filter
uin 17646 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-18more like thismore than 2024-03-18
answer text <p>The Spring Budget 2024 announced that the Government is protecting the day-to-day funding of the National Health Service in England, providing an extra £2.45 billion in 2024/25. This will allow the NHS to continue to focus on reducing waiting times, and will bring the NHS’s resource budget in 2024/25 to £164.9 billion. This means that NHS funding will increase from 2023/24, and equates to a real terms increase of 13% since 2019/20.</p><p>An additional £3.4 billion of capital funding announced at the budget will aid the NHS’ technological and digital transformation over three years, between 2025/26 and 2027/28. This will provide wider benefits to quality of care and patient outcomes, such as better prevention, and patients living longer and healthier lives, as a result of receiving scans earlier. Devolved administrations, including Scotland, will benefit from additional funding through the Barnett formula.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson remove filter
question first answered
less than 2024-03-18T10:09:59.673Zmore like thismore than 2024-03-18T10:09:59.673Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4638
label Biography information for Mr Tanmanjeet Singh Dhesi more like this